Drugs / WR909388
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03436160 | Aug → Nov 2018 | malaria | U.S. Army Medical Research and Development Command | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | WR909388 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03436160 ↗ |
| Modality | Small molecule | “three Carbon-14 radio labeled (14C) triazine compounds WR826647, WR909388, WR909390” NCT03436160 ↗ |